Also, CR’s improving order trends, investment in technology, efforts to develop products and focus on commercial excellence will likely boost its performance in the quarters ahead. Also, by removing all asbestos-related liabilities and obligations from CR’s balance sheet, the transaction will increase its annual free cash flow, aiding in long-term value creation for its stakeholders. Crane Holdings Co. CR is well-poised to gain from its diverse end markets, including general industrial, chemical and pharmaceutical markets despite pandemic impacts, inflationary pressures and supply-chain issues.